Fujian Haixi Pharmaceuticals Co., Ltd.

HK$152.20As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2637Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM 66.02
TSR TTM 27.05%
Mkt cap HK$11.98B
ROIC 48.64%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$197
29.20%
(90.22%)
Sell 1|8|5|9|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
3.94
4.10
4.37
4.30
27.81%
19.49%
16.96%
14.73%
Revenue¥M
619.6
622.0
603.7
600.2
(0.58%)
2.09%
(4.91%)
(5.93%)
Peers (US$1.528B)
Cap (US$)
PE
1.581B
—
1.515B
13.84x
1.503B
343.0x
Capital
TTM
5Y
10Y
Leveragex
0.979
0.635
0.381
EBIT/Intx
12.74
2.804
1.983
Own earn%
412.23
60.88
60.62
Sh yield%
16.99
36.84
37.00
Owners
Insiders/Inst%
13.51
59.01
Short interest%
0.71
SBC / revenue%
5.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
7–12
$1 testx
0.0
Incr. ROIC%
11